<DOC>
	<DOCNO>NCT01942785</DOCNO>
	<brief_summary>To explore anti-impulsive anti-aggressive property brexpiprazole naturalistic setting depress patient irritability .</brief_summary>
	<brief_title>Study Brexpiprazole Adjunctive Treatment Irritability Patients With Major Depressive Disorder Inadequate Response Antidepressant Therapy</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Brexpiprazole</mesh_term>
	<criteria>Main selection criterion screen visit : The patient Major Depressive Episode ( MDE ) associate Major Depressive Disorder ( MDD ) diagnose accord Diagnostic Statistical Manual Mental Disorders , 4th edition , Text Revision ( DSMIVTR™ ) . The current MDE confirm use Mini International Neuropsychiatric Interview ( MINI ) The patient inadequate response least one antidepressant treatment ( include treatment patient take screen ) current MDE , document selfreport less predefined percentage response Massachusetts General Hospital Antidepressant Treatment Response Questionnaire ( ATRQ ) . Predefined MADRS total score Predefined CGIS total score The patient current MDE ≥10 week The patient receive SSRI SNRI antidepressant treatment ≥6 week , dosage ≥2 week Predefined Inventory Depressive Symptomatology ClinicianRated 30 item ( IDSC 30 ) Item 6 Mood ( irritable ) score Main inclusion criterion baseline visit : The patient still fulfil DSMIVTR™ criterion MDE Predefined MADRS total score Predefined CGII ( Leadin period ) score The patient receive SSRI SNRI antidepressant treatment adequate dos entire leadin period The patient le predefined percentage decrease MADRS score end leadin period compare screen visit The patient still predefined IDSC 30 Item 6 Mood ( Irritable ) score The patient current psychiatric disorder Axis I disorder ( DSMIVTR™ criterion ) , establish principal diagnosis , MDD . All anxiety disorder , impulsecontrol disorder intermittent explosive disorder , well nonsuicidal selfinjury exclude diagnosis far consider principal diagnosis . The patient current Axis II ( DSMIVTR™ ) diagnosis antisocial , borderline , paranoid , schizoid , schizotypical , histrionic personality disorder . The patient experienced/experiences hallucination , delusion , psychotic symptomatology current MDE . The patient , opinion investigator base CSSRS rating , significant risk suicide . The patient start formal cognitive behavioural therapy systematic psychotherapy within 6 week prior screen , plan start therapy study . Any ongoing formal psychotherapy initiate 6 week prior screen continue methodology frequency intensity entire study . The patient current diagnosis history substance abuse dependence ( exclude nicotine caffeine ) alcohol abuse dependence ( DSMIVTR™ criterion ) &lt; 6 month prior Screening Visit . The patient report adjunctive treatment antipsychotic medication together antidepressant 3 week current MDE . The patient receive electroconvulsive therapy ( ECT ) &lt; 6 month prior Screening Visit time current MDE ( duration longer 6 month ) . The patient vagus nerve stimulation deep brain stimulation device implant management depression . Other inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>